AI-Driven Prediction of Mutation Interactions for Smarter Protein Design

AI-Driven Epistasis Prediction for Protein Engineering

Engineering proteins often requires introducing multiple mutations to improve activity, stability, specificity, or manufacturability.

However, mutations rarely behave independently.

A mutation that improves protein performance individually may become neutral—or even detrimental—when combined with other mutations.

Neoncorte Bio applies AI-driven epistasis prediction to identify beneficial mutation combinations and support more efficient protein engineering programs.

Why Epistasis Prediction Matters

Modern protein engineering frequently involves optimizing multiple properties simultaneously.
Without accounting for mutation interactions, development programs may require:
  • Larger experimental libraries
  • Additional engineering cycles
  • Increased screening effort
  • Higher development costs
  • Longer timelines
Epistasis prediction helps prioritize mutation combinations with greater potential for successful experimental validation.

Application Areas

AI-Driven Epistasis Prediction for Protein Engineering
  • Industrial Enzyme Engineering

    Improve industrial enzymes through informed selection of multi-mutation variants.
    Benefit: More efficient optimization with reduced experimental screening.
  • Synthetic Biology

    Engineer proteins used in synthetic biological systems where multiple performance characteristics must be optimized simultaneously.
    Benefit: Faster design iterations and improved engineering efficiency.
  • Specialty Chemical Biocatalysis

    Develop enzymes for selective industrial synthesis requiring coordinated improvements in multiple protein properties.
    Benefit: Better-performing protein variants with fewer engineering cycles.
  • Pharmaceutical Protein Development

    Support optimization of therapeutic proteins and biocatalysts during lead development.
    Benefit: Better prioritization of engineering strategies.
  • Academic & Research Programs

    Support computational protein engineering research involving mutation interaction analysis.
    Benefit: Data-driven hypothesis generation and experimental planning.
AI-Driven Epistasis Prediction for Protein Engineering

AI-Guided Prediction of Mutation Interactions

Neoncorte Bio integrates artificial intelligence with computational protein engineering to analyze complex relationships between protein sequence, structure, and function.
Our computational workflows may incorporate:
  • Machine learning
  • Protein language models
  • Structural biology
  • Evolutionary sequence analysis
  • Computational protein design
  • Design-Build-Test-Learn (DBTL) methodologies
These approaches support the identification of mutation combinations that warrant experimental investigation.

Protein Engineering Challenges We Address

Epistasis prediction can support optimization of:
  • Catalytic activity
  • Thermostability
  • pH stability
  • Solvent tolerance
  • Oxidative stability
  • Enantioselectivity
  • Substrate specificity
  • Recombinant expression
  • Solubility
  • Aggregation resistance
  • Manufacturability
Rather than evaluating mutations independently, our approach considers how combinations of mutations may influence overall protein performance.

From Prediction to Protein Engineering

Predicting mutation interactions is only one part of successful protein engineering.
Neoncorte Bio integrates epistasis prediction with:
  • AI-guided protein design
  • Multi-parameter optimization
  • Protein fitness landscape prediction
  • Candidate prioritization
  • Design-Build-Test-Learn (DBTL) workflows
  • Experimental planning
This integrated workflow helps accelerate iterative protein optimization while supporting informed engineering decisions.
AI Driven Epistasis Prediction for Protein Engineering

What Neoncorte Bio Delivers

  • AI-driven epistasis prediction
  • Mutation interaction analysis
  • Protein sequence optimization
  • Computational protein engineering
  • Candidate prioritization
  • Design-Build-Test-Learn (DBTL) support
  • Confidential B2B protein engineering partnerships

Who We Work With

  • Industrial biotechnology companies
  • Pharmaceutical developers
  • Enzyme manufacturers
  • Synthetic biology startups
  • CDMOs and CROs
  • Research institutes
  • Agricultural biotechnology companies
  • Specialty chemical manufacturers
Frequently Asked Questions (FAQs)

Neoncorte Bio

Where AI Meets Biotechnology
Neoncorte Bio is at the forefront of the convergence between artificial intelligence and enzyme engineering. Our team comprises experts in computational biology, bioinformatics, and machine learning, all driven by a mission to accelerate innovation in enzyme design. By leveraging our advanced AI models, we provide unparalleled solutions that enhance efficiency, reduce costs, and push the boundaries of what's possible in enzyme engineering
Proud Member of Leading Global AI Programs
Neoncorte Bio is part of the NVIDIA Inception and Nebius for Startups programs — two of the world’s leading ecosystems for high-performance AI innovation. These partnerships strengthen our ability to deliver next-generation AI-driven protein, enzyme, and aptamer engineering.
  • NVIDIA Inception Neoncorte Bio AI life sciences company
    As a member of NVIDIA Inception, Neoncorte Bio gains access to cutting-edge GPU technologies, expert guidance, and a global AI ecosystem that supports companies from prototype to production. The program empowers us to explore new AI opportunities and build high-performance biological design pipelines powered by NVIDIA’s world-class platform.
  • Nebius AI life sciences Neoncorte Bio
    Through Nebius for Startups, we gain access to high-performance compute infrastructure optimized for large-scale AI workloads, along with hands-on technical guidance and a strong community of innovative AI companies. Nebius enables us to train and deploy complex biological models more efficiently — accelerating enzyme, protein, and aptamer design while supporting rapid scaling of our R&D pipelines.
Publications
Scientific Publication of Neoncorte Bio Team
  • Modification of natural enzymes to introduce new properties and enhance existing ones is a central challenge in bioengineering. This study is focused on the development of Taq polymerase mutants that show enhanced reverse transcriptase (RTase) activity while retaining other desirable properties such as fidelity, 5′-3′ exonuclease activity, effective deoxyuracil incorporation, and tolerance to locked nucleic acid (LNA)-containing substrates.
  • The transcriptomic data are being frequently used in the research of biomarker genes of different diseases and biological states. The most common tasks there are the data harmonization and treatment outcome prediction. Both of them can be addressed via the style transfer approach. Either technical factors or any biological details about the samples which we would like to control (gender, biological state, treatment, etc.) can be used as style components.
  • List of all Neoncorte Bio publications dedicated to Molecular Biology, Biotechnology, Artificial Intelligence and Artificial Neural Networks, published mostly by Nikolay Russkikh, CEO of Neoncorte Bio

Our Expertise in Action
With extensive experience in AI applications and software engineering tailored to the life sciences, we specialize in solving complex challenges and delivering innovative solutions for our customers. Our work demonstrates a deep understanding of cutting-edge technologies and their application in the real world.
Here are examples of the types of projects we have successfully delivered:
  • Automated NGS Data Analysis:
    Designed a production-grade solution for the automated processing, annotation, and analysis of Next-Generation Sequencing (NGS) data.
  • Single-Cell Data Integration:
    Built state-of-the-art tools for integrating multimodal single-cell data, achieving recognition for technical excellence.
  • Metagenomic Classification Algorithms:
    Developed advanced methods for classifying sequencing reads in metagenomics research.
  • High-Throughput Image Processing Pipelines:
    Engineered an efficient pipeline to process millions of sequencing images with exceptional accuracy.
  • Cell Counting via AI:
    Created a computer vision solution for precise cell counting in microphotography images, streamlining data analysis.
Get in touch with our team
Phone: +1-503-754-3958
Email: contact@neoncorte.com